Palaniappan Kulanthaivel

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Amita Patnaik, Lee S. Rosen, Sara M. Tolaney et al. · Cancer Discovery · 2016 · 740 citations · Full text

Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft

Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel et al. · Drug Metabolism and Disposition · 2015 · 270 citations

Balanol: a novel and potent inhibitor of protein kinase C from the fungus Verticillium balanoides

Palaniappan Kulanthaivel, Yali F. Hallock, Christie Boros et al. · Journal of the American Chemical Society · 1993 · 211 citations

Fungal Cell Biology, Potent Inhibitor, Altmetric Attention Score +19

SELECTIVE METABOLISM OF VINCRISTINE IN VITRO BY CYP3A5

Jennifer B. Dennison, Palaniappan Kulanthaivel, Robert J. Barbuch et al. · Drug Metabolism and Disposition · 2006 · 171 citations

A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds

Andrew M. Sawayama, Michael M. Y. Chen, Palaniappan Kulanthaivel et al. · Chemistry - A European Journal · 2009 · 143 citations · Full text

Drug Lead Diversification, Engineering, Metabolomic Profiling +17